IRADIMED CORP — Director's Dealing 2019

Nov 5, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2019-11-04

Reporting Person: Nardi Steven M. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-04	Common Stock	A	1250	$9.84	Acquired	1250	Direct
2019-11-04	Common Stock	S	1250	$24.36	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-11-04	Stock Option (Right to Buy)	$9.84	M	1250	Disposed	2024-12-15	Common Stock (1250)	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $24.32 to $24.47. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2: This option, representing a right to purchase a total of 5,000 shares, was granted on 12/15/2014 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.